FDA approves Genentech's Enspryng as first at-home subcutaneous treatment for thyroid eye disease

argenx reports positive Phase 2 results for FB102 in coeliac disease

Mozart Therapeutics presents MTX-101 clinical and preclinical data at EASD Annual Meeting

CSL and Alentis partner for lixudebart development and commercialisation for rare kidney and liver diseases

Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages

Abogen enters Novartis licensing and option agreement to advance RNA programs

Ascletis reports positive results from ASC50 clinical study for treatment of plaque psoriasis

Ionis reports positive Phase 3 sefaxersen data in IgA nephropathy

AbbVie secures EU approval for RINVOQ in polyarticular juvenile idiopathic arthritis

GSK to acquire trispecific T cell-engager from Chimagen for multiple myeloma

FDA grants Priority Review to Genentech's Enspryng for MOGAD

Kali Therapeutics' KT501 Investigational New Drug application cleared by US FDA

Lilly to acquire Merida Biosciences in USD2.875bn deal

FDA approves Johnson & Johnson's IMAAVY (nipocalimab-aahu) to treat warm autoimmune haemolytic anaemia

Antengene's Phase I study of ATG-201 in B cell-related autoimmune diseases approved in Australia